These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37741007)

  • 1. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study.
    Rhee J; Chang VC; Cheng I; Calafat AM; Botelho JC; Shearer JJ; Sampson JN; Setiawan VW; Wilkens LR; Silverman DT; Purdue MP; Hofmann JN
    Environ Int; 2023 Oct; 180():108197. PubMed ID: 37741007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective nested case-control study of serum concentrations of per- and polyfluoroalkyl substances and aggressive prostate cancer risk.
    Rhee J; Barry KH; Huang WY; Sampson JN; Hofmann JN; Silverman DT; Calafat AM; Botelho JC; Kato K; Purdue MP; Berndt SI
    Environ Res; 2023 Jul; 228():115718. PubMed ID: 36958379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma.
    Shearer JJ; Callahan CL; Calafat AM; Huang WY; Jones RR; Sabbisetti VS; Freedman ND; Sampson JN; Silverman DT; Purdue MP; Hofmann JN
    J Natl Cancer Inst; 2021 May; 113(5):580-587. PubMed ID: 32944748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of per- and polyfluorinated substances and risk of B-cell non-Hodgkin lymphoma.
    Rhee J; Koponen J; Sampson JN; Keil AP; Ward MH; Hofmann JN; Huang WY; Silverman DT; Rantakokko P; Purdue MP
    Environ Int; 2024 Oct; 192():109058. PubMed ID: 39388845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society's Cancer Prevention Study II LifeLink Cohort.
    Winquist A; Hodge JM; Diver WR; Rodriguez JL; Troeschel AN; Daniel J; Teras LR
    Environ Health Perspect; 2023 Dec; 131(12):127007. PubMed ID: 38088576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma per- and polyfluoroalkyl substance mixtures during pregnancy and duration of breastfeeding in the New Hampshire birth cohort study.
    Romano ME; Gallagher LG; Price G; Crawford KA; Criswell R; Baker E; Botelho JC; Calafat AM; Karagas MR
    Int J Hyg Environ Health; 2024 May; 258():114359. PubMed ID: 38521049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study.
    Averina M; Huber S; Almås B; Brox J; Jacobsen BK; Furberg AS; Grimnes G
    Environ Res; 2024 Feb; 242():117703. PubMed ID: 37984785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nested Case-Control Study of Serum Per- and Polyfluoroalkyl Substances and Testicular Germ Cell Tumors among U.S. Air Force Servicemen.
    Purdue MP; Rhee J; Denic-Roberts H; McGlynn KA; Byrne C; Sampson J; Botelho JC; Calafat AM; Rusiecki J
    Environ Health Perspect; 2023 Jul; 131(7):77007. PubMed ID: 37458713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the cancer prevention Study-II LifeLink cohort study.
    Troeschel AN; Teras LR; Hodge JM; Rodriguez J; Wang Y; Daniel J; Diver WR; Winquist A
    Environ Res; 2024 Oct; 259():119560. PubMed ID: 38971361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
    Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and neurobehavior in US children through 8 years of age: The HOME study.
    Vuong AM; Webster GM; Yolton K; Calafat AM; Muckle G; Lanphear BP; Chen A
    Environ Res; 2021 Apr; 195():110825. PubMed ID: 33545124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Chang VC; Rhee J; Berndt SI; Moore SC; Freedman ND; Jones RR; Silverman DT; Gierach GL; Hofmann JN; Purdue MP
    Int J Cancer; 2023 Aug; 153(4):775-782. PubMed ID: 36843273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to per- and polyfluoroalkyl substances in association with autism spectrum disorder in the MARBLES study.
    Oh J; Bennett DH; Calafat AM; Tancredi D; Roa DL; Schmidt RJ; Hertz-Picciotto I; Shin HM
    Environ Int; 2021 Feb; 147():106328. PubMed ID: 33387879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
    Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
    Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances.
    Crawford L; Halperin SA; Dzierlenga MW; Skidmore B; Linakis MW; Nakagawa S; Longnecker MP
    Environ Int; 2023 Feb; 172():107734. PubMed ID: 36764183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.